Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1)

Immunity

Volumn 5, Issue 4, 1996, Pages 311-317

  Chambers, Benedict J ^a   Salcedo, Margarita ^a   Ljunggren, Hans Gustaf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; ARTICLE; BONE MARROW; CYTOTOXICITY; DENDRITIC CELL; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030273745     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80257-5     Document Type: Article

References (33)

1. Allison, J.P. (1994). CD28-B7 interactions in T cell activation. Curr. Opin. Immunol. 6, 414-419.
2. Azuma, M., Cayabyab, M., Buck, D., Phillips, J.H., and Lanier, L.L. (1992). Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. J. Immunol. 149, 1115-1123.
3. Cavallo, F., Martin-Fontecha, A., Bellone, M., Heltai, S., Gatti, E., Tornaghi, P., Freschi, M., Forni, G., Dellabona, P., and Casorati, G. (1995). Co-expression of B7-1 and ICAM-1 on tumors is required for rejection and the establishment of a memory response. Eur. J. Immunol. 25, 1154-1162.
4. Chen L., McGowan, P., Ashe, S., Johnston, J., Li, Y., Hellström, I., and Hellström, K.E. (1994). Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity. J. Exp. Med. 179, 523-532.
5. Correa, I., Corral, L., and Raulet, D.H. (1994). Multiple natural killer cell-activating signals are inhibited by major histocompatibility complex class I expression in target cells. Eur. J. Immunol. 24, 1323-1331.
6. Geldhof, A.B., Raes, G., Bakkus, M., Devos, S., Thielmans, K., and De Baetselier, P. (1995). Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity. Cancer Res. 55, 2730-2733.
7. + cytolytic T cells by suppressing or eliminating dendritic cells. J. Immunol. 136, 3567-3571.
8. Glas, R., Sturmhöfel, K., Hämmerling, G.J., Kärre, K., and Ljunggren, H.G. (1992). Restoration of a tumorigenic phenotype by β2-microglobulin transfectionto EL-4 mutant cells. J. Exp. Med. 175, 843-846.
9. Gumperz, J.E., and Parham, P. (1995). The enigma of the natural killer cell. Nature 378, 245-248.
10. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R.M. (1992). Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony stimulating factor. J. Exp. Med. 176, 1693-1702.
11. Kägi, D., Lederman, B., Bürki, K., Seiler, P., Odermatt, B., Olsen, K.J., Podack, E.R., Zinkernagel, R.M., and Hengartner, H. (1994). Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37.
12. + IL-2-activated natural killer cells. Nature 358, 66-70.
13. Kärre, K. (1995). Express yourself or die: peptides, MHC molecules and NK cells. Science 267, 978-979.
14. Kärre, K., Ljunggren, H.G., Piontek, G., and Kiessling, R. (1986). Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defence strategy. Nature 319, 675-678.
15. + T cells. Science 248, 1227-1230.
16. Lanier, L.L., and Philips, J.H. (1996). Inhibitory MHC class I receptors on NK cells and T cells. Immunol. Today 17, 86-91.
17. Linsley, P.S., and Ledbetter, J.A. (1993). The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191-212.
18. Ljunggren, H.G., and Kärre, K. (1985). Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanisms. J. Exp. Med. 162, 1745-1759.
19. Ljunggren, H.G., and Kärre, K. (1990). In search of the "missing self": MHC molecules and NK cell recognition. Immunol. Today 11, 237-244.
20. Montel, A.H., Morse, P.A., and Brahmi, Z. (1995a). Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line. Cell. Immunol. 160, 104-114.
21. Montel, A.H., Bochan, M.R., Hobbs, J.A., Lynch, D.H., and Brahmi, Z. (1995b). Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol. 166, 236-246.
22. Nandi, D., Gross, J.A., and Allison, J.P. (1994). CD28-mediated co-stimulation is necessary for optimal proliferation of murine NK cells. J. Immunol. 152, 3361-3369.
23. Racoosin, E.L., and Swanson, J.A. (1989). Macrophage colony stimulating factor (rM-CSF) stimulates pinocytosis in bone marrow derived macrophages. J. Exp. Med. 170, 1635-1648.
24. Raulet, D.H. (1996). Recognition events that inhibit and activate natural killer cells. Curr. Opin. Immunol. 8, 372-377.
25. Roger, R., Bréard, J., Comisso, M., Bohuon, C., Pallardy, M., and Bertoglio, J. (1996). CD28-mediated cytotoxicity of YT natural killer cells on B7-positive targets induces rapid necrotic death independent of granule exocytosis. Cell. Immunol. 168, 24-32.
26. Shahinian, A., Pfeffer, K., Lee, K.P., Kundig, T.M., Kishihara, K., Wakeham, A., Kawai, K., Ohashi, P.S., Thompson, C.B., and Mak, T. W. (1993). Differential T cell co-stimulatory requirements in CD28-deficient mice. Science 261, 609-612.
27. Sharpe, A.S. (1995). Analysis of lymphocyte co-stimulation in vivo using transgenic and "knockout" mice. Curr. Opin. Immunol. 7, 389-395.
28. Tivol, E.A., Boriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
29. Waterhouse, P., Penninger, J.M., Timms, E., Wakeham, A., Shahinian, A., Lee, K.P., Thompson, C.B., Griesser, H., and Mak, T.W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270, 985-988.
30. Wu, T.C., Huang, A.Y.C., Jaffee, E.M., Levitsky, H.I., and Pardoll, D.M. (1995). A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 182, 1415-1421.
31. Yeh, K.Y., Pulaski, B.A., Woods, M.L., McAdam, A.J., Gaspari, A.A., Frelinger, J.G., and Lord, E.M. (1995). B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. Cell. Immunol. 165, 217-224.
32. Yokoyama, W.M., and Seaman, W.E. (1993). The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: the NK gene complex. Annu. Rev. Immunol. 11, 613-635.
33. Yu, Y.Y., George, T., Dorfman, J., Roland, J., Kumar, V., and Bennett, M. (1996). The role of Ly49A and 5E6(Ly49C) molecules in hybrid resistance mediated by murine natural killer cells against normal T cell blasts. Immunity 4, 67-76.